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CT Assessment of Coronary Artery Disease
Trends and Clinical Implications*Paul Schoenhagen, MD,y Marc Dewey, MDz
Cleveland, Ohio; and Berlin, GermanyIn this issue of iJACC, Bettencourt et al. (1)
compare myocardial scar imaging with computed
tomography (CT) and cardiac magnetic resonance
(CMR). The data are based on a comprehensive
clinical CT protocol, including coronary computed
See page 1062
tomography angiography (CTA), myocardial stress–
rest computed tomography perfusion (CTP), and
computed tomography delayed enhancement scar
imaging (CTDE). The report is part of a series of
recent papers using apparently the same patient
cohort (1–3). The prior publications demonstrate
that stress CTP imaging has diagnostic accuracy
comparable to stress–rest CMR and, when added to
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contents of this paper to disclose.creases the diagnostic accuracy of CTA. In the
current paper, the authors show that the addition of
CTDE does not provide further diagnostic value for
the identiﬁcation of patients with functionally sig-
niﬁcant CAD (deﬁned as luminal stenosis by con-
ventional angiography $90% [$50% in the left
main stem], or fractional ﬂow reserve [FFR] #0.8
in vessels >2 mm).
What future impact could the results have for
cardiac CT? The diagnostic goals in symptomatic
patients with suspected CAD are: 1) identiﬁcation
and localization of hemodynamically signiﬁcant le-
sions, deﬁned based on severity of luminal stenosis
and/or effect on myocardial perfusion; 2) prediction
of risk for future cardiovascular events; and 3) opti-
mization of subsequent therapeutic management.
Based on a signiﬁcant amount of data from single-
and multi-center studies intraindividually comparing
noninvasive with invasive coronary angiography,
CTA has been shown to be a useful noninvasive test
(4). CTA is characterized by a high negative pre-
dictive value (>95%) and low negative likelihood
ratio (<0.05), and can therefore reliably exclude
signiﬁcant stenosis in selected patient populations
with intermediate pre-test probability (5). This is
applied to patients presenting with stable chest pain
or with acute chest pain in the emergency department
(6,7). However, there are several technical limitations
compared with invasive coronary angiography: 1)
longer image acquisition windows (temporal resolu-
tion >75 ms vs. >20 ms), with increased suscepti-
bility to motion artifacts; and 2) lower pixel
dimensions (spatial resolution 0.5 mm2 vs. 0.1 mm2),
with increased susceptibility to volume averaging.
Volume averaging is most obvious for calciﬁed pla-
ques (“calcium blooming”) and indicates that a small
calciﬁed subvolume of dense calcium can increase the
density of an entire voxel above the calcium
threshold. These limitations degrade image quality
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and are associated with false-positive CTA results,
potentially leading to increased downstream testing
(8,9). Therefore, coronary CTA is typically not
recommended in patients with known signiﬁcant
CAD, most coronary stents, diffuse calciﬁed ath-
erosclerotic disease, and those with a high and
irregular heart rate, excluding a signiﬁcant percent-
age of patients.
These technical limitations have been alleviated,
but not resolved, with the latest, most advanced
scanner generations, and only gradual advances are
expected in the near future. Another approach to
increase the value of CT is to evaluate additional
characteristics of coronary lesions, and speciﬁcally,
their functional signiﬁcance, that is, myocardial
ischemia/scar. The role of perfusion imaging is well
established with positron emission tomography/
single-photon emission computed tomography,
stress echocardiography, and stress CMR (10). Stress
CTP is feasible, but data are still relatively limited
(11,12). The series of papers byBettencourt et al. (1–3)
and recently published results from CARS-320
(Coronary Artery Stent Evaluation With 320-slice
Computed Tomography–TheCArS 320 Study) (13)
provide evidence that combined coronary CTA and
myocardial CTP may allow improved diagnostic
accuracy compared with CTA alone, in patients with
native CAD or stents.
In the current report, Bettencourt et al. (1)
demonstrate that the addition of CTDE scar imag-
ing did not add further diagnostic value. Segments
with scar (CTDEþ), but without ischemia (CTP)
were reclassiﬁed as signiﬁcant disease. However,
most segments with scar also demonstrated ischemia
(9 of 11), explaining the lack of diagnostic impact.
The negative results may simply demonstrate that
scar imaging is not a good marker for the identiﬁ-
cation of functionally signiﬁcant CAD. In fact, data
from positron emission tomography/single-photon
emission computed tomography and CMR demon-
strate that the value of scar imaging is rather its
prognostic value for future cardiovascular events and
mortality (14).
The current study was too small to look at follow-
up events, and there are very limited data describing
the prognostic value of CTDE. On the other hand,
extensive data have accumulated demonstrating theprognostic information of disease burden deﬁned
by CTA (stenosis and plaque burden) on fu-
ture cardiovascular events (6,15). Speciﬁcally, a
negative coronary CTA is associated with a pooled
annualized event rate of 0.17% per year for major
adverse cardiac events and 0.15% for death or
myocardial infarction, comparable to healthy, low-
risk populations adjusted for age.
On the basis of the preceding, we believe that the
following trends can be identiﬁed for appropriate
use of cardiac CT:
 Improvement in the selection of the most suitable
patient populations remains important (16).
 Evaluation of the impact of CTA on therapeutic
management is critical and is the objective of the
large U.S. multicenter PROMISE (PROspective
Multicenter Imaging Study for Evaluation of
Chest Pain) (17) and RESCUE (Randomized
Evaluation of Patients With Stable Angina
Comparing Diagnostic Examinations) trials (18).
 In patients with intermediate stenoses on CTA,
subsequent stress CTP may direct management,
similar to invasive FFR (19). This is examined in
the CORE320 (Combined Coronary Athero-
sclerosis and Myocardial Perfusion Evaluation
Using 320 Detector Row Computed Tomogra-
phy) trial (20).
 The recently described concept of CT-FFR is
interesting, but incompletely understood, and
further evaluation will be important to deﬁne its
potential clinical role (21).
 Lastly, although feasible and intriguing, current
data are not sufﬁcient to support clinical use of
CTDE scar imaging in the diagnostic work-up
of patients with suspected CAD.
Coronary CTA has developed into a valuable
diagnostic option for certain symptomatic patient
populations. CTP and perhaps CTDE will likely
expand CTA’s application, but further evaluation of
their impact on therapeutic decision making is
necessary, optimally in trials with clinical endpoints.
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